These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 27206284

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I, Minář L, Felsinger M, Anton M, Bednaříková M, Hausnerová J, Jandáková E, Weinberger V.
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [Abstract] [Full Text] [Related]

  • 4. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F, Meinhold-Heerlein I.
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [Abstract] [Full Text] [Related]

  • 5. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M, Høgdall CK, Mosgaard BJ.
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [Abstract] [Full Text] [Related]

  • 6. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ.
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [Abstract] [Full Text] [Related]

  • 7. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
    Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D.
    Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
    [Abstract] [Full Text] [Related]

  • 8. An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
    Chi DS, Musa F, Dao F, Zivanovic O, Sonoda Y, Leitao MM, Levine DA, Gardner GJ, Abu-Rustum NR, Barakat RR.
    Gynecol Oncol; 2012 Jan; 124(1):10-4. PubMed ID: 21917306
    [Abstract] [Full Text] [Related]

  • 9. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
    Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D.
    J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
    [Abstract] [Full Text] [Related]

  • 10. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC, Lai CR, Chang WH, Wen KC, Chen YJ, Juang CM, Yen MS, Wang PH.
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [Abstract] [Full Text] [Related]

  • 11. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
    Ma Y, Li Y, Cui H, Liang XD, Tang ZJ, Li XP, Zhao Y, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
    [Abstract] [Full Text] [Related]

  • 12. Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer.
    Li S, Manning-Geist B, Gockley A, Ramos A, Sisodia RC, Del Carmen M, Growdon WB, Horowitz N, Berkowitz R, Worley M.
    Int J Gynecol Cancer; 2020 Jul; 30(7):1052-1057. PubMed ID: 32487686
    [Abstract] [Full Text] [Related]

  • 13. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
    Barlin JN, Dao F, Bou Zgheib N, Ferguson SE, Sabbatini PJ, Hensley ML, Bell-McGuinn KM, Konner J, Tew WP, Aghajanian C, Chi DS.
    Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
    [Abstract] [Full Text] [Related]

  • 14. The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
    Toptas T, Pestereli E, Simsek T, Bozkurt S, Erdogan G, Karaveli S.
    J Cancer Res Ther; 2018 Jun; 14(3):587-592. PubMed ID: 29893323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T, Tanaka YO, Matsumoto K, Satoh T, Yoshikawa H, Minami M.
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [Abstract] [Full Text] [Related]

  • 17. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL, Evans T, Pearmain P, Askew S, Singh K, Chan KK, Ganesan R, Hirschowitz L.
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS, Leitao MM, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, Levine DA, Jewell EL, Brown CL, Abu-Rustum NR, Charlson ME, Chi DS.
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ, Bristow RE, Ryu HS.
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
    Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N.
    J Clin Oncol; 2015 Aug 01; 33(22):2457-63. PubMed ID: 26124480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.